Comparison of the Transcriptomic Signatures in Pediatric and Adult CML.

Comparison of the Transcriptomic Signatures in Pediatric and Adult CML.
复制标题

DOI:
10.3390/cancers13246263
复制
发表时间:
2021-12-14
期刊:
影响因子:
5.2
通讯作者:
Sakamoto KM
Sakamoto KM
中科院分区:
医学2区
文献类型:
--
作者:
Youn M;Smith SM;Lee AG;Chae HD;Spiteri E;Erdmann J;Galperin I;Jones LM;Donato M;Abidi P;Bittencourt H;Lacayo N;Dahl G;Aftandilian C;Davis KL;Matthews JA;Kornblau SM;Huang M;Sumarsono N;Redell MS;Fu CH;Chen IM;Alonzo TA;Eklund E;Gotlib J;Khatri P;Sweet-Cordero EA;Hijiya N;Sakamoto KM

文献摘要

参考文献

被引文献

相似文献

To investigate whether pediatric and adult chronic myeloid leukemia (CML) have unique molecular characteristics, we studied the transcriptomic signature of pediatric and adult CML cells using high-throughput RNA sequencing. We identified differentially expressed genes and pathways unique to pediatric CML cells compared to adult CML cells. The Rho pathway was significantly dysregulated in pediatric CML cells compared to adult CML cells, suggesting the potential importance in the pathogenesis of pediatric CML. Our study is the first to compare transcriptome profiles of CML across different age groups. A better understanding of the biology of CML across different ages may inform future treatment approaches. Children with chronic myeloid leukemia (CML) tend to present with higher white blood counts and larger spleens than adults with CML, suggesting that the biology of pediatric and adult CML may differ. To investigate whether pediatric and adult CML have unique molecular characteristics, we studied the transcriptomic signature of pediatric and adult CML CD34+ cells and healthy pediatric and adult CD34+ control cells. Using high-throughput RNA sequencing, we found 567 genes (207 up- and 360 downregulated) differentially expressed in pediatric CML CD34+ cells compared to pediatric healthy CD34+ cells. Directly comparing pediatric and adult CML CD34+ cells, 398 genes (258 up- and 140 downregulated), including many in the Rho pathway, were differentially expressed in pediatric CML CD34+ cells. Using RT-qPCR to verify differentially expressed genes, VAV2 and ARHGAP27 were significantly upregulated in adult CML CD34+ cells compared to pediatric CML CD34+ cells. NCF1, CYBB, and S100A8 were upregulated in adult CML CD34+ cells but not in pediatric CML CD34+ cells, compared to healthy controls. In contrast, DLC1 was significantly upregulated in pediatric CML CD34+ cells but not in adult CML CD34+ cells, compared to healthy controls. These results demonstrate unique molecular characteristics of pediatric CML, such as dysregulation of the Rho pathway, which may contribute to clinical differences between pediatric and adult patients.
DOI: 10.1074/jbc.m112397200
发表时间: 2002-04-05
影响因子: 4.8
作者:
Bassermann, F;Jahn, T;Duyster, J
通讯作者: Duyster, J
DOI: 10.1038/sj.leu.2403136
发表时间: 2003-12-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Beillard, E;Pallisgaard, N;Gabert, J
通讯作者: Gabert, J
DOI: 10.1038/leu.2012.331
发表时间: 2013-05-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Badger-Brown, K. M.;Gillis, L. C.;Barber, D. L.
通讯作者: Barber, D. L.
DOI: 10.1038/sj.onc.1206626
发表时间: 2003-09-25
期刊: ONCOGENE
影响因子: 8
作者:
Harnois, T;Constantin, B;Bourmeyster, N
通讯作者: Bourmeyster, N
DOI: 10.1038/nm.4439
发表时间: 2018-01
期刊: Nature medicine
影响因子: 82.9
作者:
Bolouri H;Farrar JE;Triche T Jr;Ries RE;Lim EL;Alonzo TA;Ma Y;Moore R;Mungall AJ;Marra MA;Zhang J;Ma X;Liu Y;Liu Y;Auvil JMG;Davidsen TM;Gesuwan P;Hermida LC;Salhia B;Capone S;Ramsingh G;Zwaan CM;Noort S;Piccolo SR;Kolb EA;Gamis AS;Smith MA;Gerhard DS;Meshinchi S
通讯作者: Meshinchi S